Skip to content
777 Sourcing.

Capability

alginate gel-raft formulation

Suppliers
1
States & provinces
1
Countries
1

1 alginate gel-raft formulation supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Aspira Therapeutics is developing Aspirvent, a first-in-class alginate-based intragastric barrier device that forms a coherent gel raft on the gastric surface to physically prevent pulmonary aspiration during anesthesia induction and sedation. The company is prioritizing patients on GLP-1 therapy before expanding into broader pre-operative gastric-content protection.

CMC developmentGMP-grade formulation manufacturingmedical device development

Related capabilities

Other processes offered by the shops that list alginate gel-raft formulation.

Browse all capabilities